Topics
Appearances (1)
2026-10-01
Drug Prices: The Real Cost of Government InterventionIn the latest episode of the Health Policy Podcast, Eric Maus, Director of Health and Science Policy at Citizens Against Government Waste, discusses the impact of government intervention on drug prices. He highlights the significant costs associated with programs like Medicare Part D and the 340B program, revealing that despite intentions to lower prices, such interventions have often led to increased costs for patients. Maus also addresses proposed legislation aimed at modernizing drug information delivery, emphasizing the need for a more efficient and cost-effective approach in healthcare policy.
Notable quotes
“Prices are kind of a main concern for people across the board, but especially in healthcare and with prescription drugs.”
“Throughout history, price controls, especially on medication, have been found to increase prices and limit access to these medicines.”
“I think it's safe to say that they would prefer a more free market approach.”
“Washington and lawmakers tend to deliver big and the results don't match it and don't deliver.”
“It's important to remember that while these issues may seem kind of abstract or in the weeds, it affects everybody who's a taxpayer.”
“These companies invest a lot in research and development and manufacturing.”
